Magsayo, Jay M.
HRN: 24-24-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/14/2023
12/21/2023
IV
500mg
Q8
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes